Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
about
Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.Indications and safety of intravenous and subcutaneous immunoglobulin therapy.Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy.Haemolysis after treatment with intravenous immunoglobulin due to anti-A.RETRACTED: Protective effects of cultured and fermented ginseng extracts against scopolamine-induced memory loss in a mouse model.
P2860
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@ast
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@en
type
label
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@ast
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@en
prefLabel
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@ast
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@en
P2860
P1433
P1476
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
@en
P2093
Matthias Wittstock
Uwe K Zettl
P2860
P2888
P356
10.1007/S00415-006-5013-Z
P478
253 Suppl 5
P577
2006-09-01T00:00:00Z